IDiyas

For the Inventor, By the Inventor

Ambler, PA, United States of America

Teresa Fernandez-Alnemri

USPTO Granted Patents = 9

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal9 out of 528 
 
Thomas Jefferson University
 patents

Years Active: 1997-2004

Loading Chart...
9 patents (USPTO):Explore Patents
1. 6797812 - Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use (2004-09-28),
2. 6432628 - Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use (2002-08-13),
3. 6407215 - Antibodies to Mch2, an apoptotic cysteine protease (2002-06-18),
4. 6359127 - MCH2, an apoptotic cysteine protease, and compositions for making and methods of using the same (2002-03-19),
5. 6340740 - Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use (2002-01-22),
6. 5985640 - Mch2, an apoptotic cysteine protease, and compositions for making and (1999-11-16),
7. 5958720 - Mch2, an apoptotic cysteine protease, and compositions for making and (1999-09-28),
8. 5856169 - Isoforms of human interleukin-1.beta. converting enzyme and methods of (1999-01-05),
9. 5672500 - Mch2, an apoptotic cysteine protease, and compositions for making and (1997-09-30),

Title: Teresa Fernandez-Alnemri: Pioneering Research in Apoptosis

Introduction

Teresa Fernandez-Alnemri, located in Ambler, PA, is a distinguished inventor known for her significant contributions to the field of apoptosis and molecular biology. With an impressive portfolio of 9 patents, she has made groundbreaking advancements that have implications in health and disease treatment.

Latest Patents

Among her notable inventions is her latest patent titled "Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use." This patent relates to an isolated nucleic acid molecule encoding a caspase-14 polypeptide or its functional fragments. Additionally, the invention covers a vector that contains the nucleic acid molecule and a host cell that harbors the vector. It also encompasses an isolated gene encoding caspase-14, including single or double-stranded nucleic acids corresponding to the coding or non-coding strands of the caspase-14 nucleotide sequence. Furthermore, it introduces isolated caspase-14 polypeptides, functional fragments, and specific antibodies that bind to them, along with methods for identifying compounds that modulate caspase-14 activity.

Career Highlights

Teresa currently works at Thomas Jefferson University, where her research has garnered significant attention in the scientific community. Her role involves exploring the mechanisms of apoptosis and how they can be manipulated for therapeutic purposes. Her dedication and innovation have fostered advances in understanding programmed cell death, a crucial area in treating various diseases, including cancer.

Collaborations

Notably, Teresa collaborates with respected colleagues such as Emad S. Alnemri and Gerald Litwack, contributing to a dynamic research environment that promotes innovation. Their collective expertise enhances the exploration of apoptotic mechanisms, enabling further breakthroughs inrelated fields.

Conclusion

Teresa Fernandez-Alnemri exemplifies the essence of innovation in the realm of science, particularly in understanding and manipulating apoptosis. With her impressive patent portfolio and collaborative efforts at Thomas Jefferson University, she significantly contributes to the future of molecular biology and therapeutic development. Her work not only impacts scientific research but also lays the foundation for future advancements in treating diseases linked to apoptosis dysregulation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…